Alvotech added to nasdaq biotech index effective monday december 23, 2024

Alvotech (nasdaq: alvo), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its stock will be added to the nasdaq biotechnology index (nasdaq: nbi). the addition comes as a part of the annual reconstitution of the index. alvotech's inclusion in the nbi will be effective when the u.s. market opens on monday, december 23, 2024.
ALVO Ratings Summary
ALVO Quant Ranking